✦ LIBER ✦

Bayesian Quantitative Disease–Drug–Trial Models for Parkinson’s Disease to Guide Early Drug Development

✍ Scribed by Joo Yeon Lee; Jogarao V. S. Gobburu

Book ID: 111767741
Publisher: American Association of Pharmaceutical Scientists
Year: 2011
Tongue: English
Weight: 737 KB
Volume: 13
Category: Article
ISSN: 1550-7416
DOI: 10.1208/s12248-011-9293-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

International guide to drugs for Parkins

International guide to drugs for Parkinson's disease

✍ Prof. Dr. W. H. Oertel; R. C. Dodel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract Pharmacotherapy of Parkinson's disease (PD) has become so effective that patients with PD can enjoy a nearly normal life, including travel for several years. The degree of international travel of patients with PD and in particular the recent increased coordination between health systems

Novel approaches to models of Alzheimer’

Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

✍ Laura Shaughnessy; Beth Chamblin; Lori McMahon; Ayyappan Nair; Mary Beth Thomas; 📂 Article 📅 2004 🏛 Humana Press Inc 🌐 English ⚖ 238 KB

Low-dose prednisolone in addition to the

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial

✍ Björn Svensson; Annelies Boonen; Kristina Albertsson; Désirée van der Heijde; Ca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of low‐dose prednisolone on joint damage and disease activity in patients with early rheumatoid arthritis (RA). ## Methods At the start of their initial treatment with a disease‐modifying antirheumatic drug (DMARD), patients with early (duration ≤1